Jump to section
To protect and enhance lives through clean air.
Rensair sells hospital-grade air purification systems that, unlike many of its competitors' rival devices, are fully portable. Rensair systems utilises state-of-the-art HEPA13 filters and ozone-free UVC light, which kill more than 99.97% of airborne pollutants. This makes it one of the most effective purification systems on the market. Recently it has also launched an IoT-enabled ventilation product that improves air quality while reducing energy use and carbon emissions by more than 50%.
Rensair has been in operation for over a decade, and began by providing air filtration solutions to Scandinavian hospitals. The company is well-established and its product has been tested in the most trying of environments. As such, Rensair has an enviable reputation within the healthcare sector and its air purification technology is now trusted by businesses across a range sectors. Its customers include the NHS, PepsiCo, Disney, GSK and the Ronald McDonald House Charities.
Rensair has attracted significant venture funding, and closed a Series A round in 2022. This capital is being invested in expansion and R&D, and Rensair has scaled rapidly, with operations in UK, Europe, the USA and Asia. The company has developed into a significant business in its market and is well-positioned to capture additional high value opportunities in both the public and private sector.
Freddie
Company Specialist at Welcome to the Jungle
May 2022
$7m
SERIES A
Frederik Hendriksen
(Co-founder)Studied at LSE and Copenhagen Business School. Worked at companies such as Groupon and Morgan Stanley before co-founding Rensair.
Christian Hendriksen
(Co-founder & CEO)Experiences include Groupon's expansion in Japan/China, VC in Africa, Investment Banking at Citi and UBS and most recently VP of International Expansion for a large US based startup (Series B).